bioAffinity Technologies
BIAF
BIAF
7 hedge funds and large institutions have $177K invested in bioAffinity Technologies in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$2.53K |
| 2 |
2
Wells Fargo
San Francisco,
California
|
$66 |
Top Sellers
| 1 |
1
Two Sigma Investments
New York
|
$40K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$174 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $79.9K | 43,642 | – | – |
|
|
2
Two Sigma Investments
New York
| $40K | 21,842 | -4,745 | -18% |
|
3
State Street
Boston,
Massachusetts
| $32.2K | 17,600 | – | – |
|
4
Creative Planning
Overland Park,
Kansas
| $22.1K | 12,095 | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $2.53K | 1,384 | +1,384 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $174 | 95 | -2,314 | -96% |
|
|
7
Wells Fargo
San Francisco,
California
| $66 | 36 | +2 | +6% |
|
|
CFGS
8
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|